Immediate withdrawal of the permission to manufacture all combinations of Tapentadol and all combinations of Caresoprodol

Gastro Resistant Tablets or Capsules, Delayed Release Tablets or Capsules as New Drugs as per Rule 2, (1)(w) of the New Drugs and Clinical Trials Rules, 2019

Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country wiithout due approval from Central Licensing Authority

FDC cleared by DCGI from 1961 to feb 2013

Grant of Blood centre licence through ONDLS portal

Validity of FSSAI recognised Food Testing Laboratories

Enforcement of Plastic Waste Management Rules

Prohibition of issuance of ASU drug licence for commercialisation of human breast milk

Ulipristal Tablets 5 mg RESTRICTED USE 

Documents required for issue of food registration certificate and licences